Alternatived Products of [ 16947-84-5 ]
Product Details of [ 16947-84-5 ]
CAS No. : 16947-84-5
MDL No. : MFCD00237342
Formula :
C16 H22 N2 O6
Boiling Point :
-
Linear Structure Formula : -
InChI Key : WJKGPJRAGHSOLM-LBPRGKRZSA-N
M.W :
338.36
Pubchem ID : 2756240
Synonyms :
Chemical Name : Z-Dap(Boc)-OH
Calculated chemistry of [ 16947-84-5 ] Expand+
Physicochemical Properties
Num. heavy atoms :
24
Num. arom. heavy atoms :
6
Fraction Csp3 :
0.44
Num. rotatable bonds :
11
Num. H-bond acceptors :
6.0
Num. H-bond donors :
3.0
Molar Refractivity :
85.43
TPSA :
113.96 ?2
Pharmacokinetics
GI absorption :
High
BBB permeant :
No
P-gp substrate :
No
CYP1A2 inhibitor :
No
CYP2C19 inhibitor :
Yes
CYP2C9 inhibitor :
No
CYP2D6 inhibitor :
No
CYP3A4 inhibitor :
No
Log Kp (skin permeation) :
-7.11 cm/s
Lipophilicity
Log Po/w (iLOGP) :
2.35
Log Po/w (XLOGP3) :
1.77
Log Po/w (WLOGP) :
1.74
Log Po/w (MLOGP) :
1.21
Log Po/w (SILICOS-IT) :
0.83
Consensus Log Po/w :
1.58
Druglikeness
Lipinski :
0.0
Ghose :
None
Veber :
1.0
Egan :
0.0
Muegge :
0.0
Bioavailability Score :
0.56
Water Solubility
Log S (ESOL) :
-2.51
Solubility :
1.04 mg/ml ; 0.00308 mol/l
Class :
Soluble
Log S (Ali) :
-3.78
Solubility :
0.056 mg/ml ; 0.000166 mol/l
Class :
Soluble
Log S (SILICOS-IT) :
-3.29
Solubility :
0.174 mg/ml ; 0.000513 mol/l
Class :
Soluble
Medicinal Chemistry
PAINS :
0.0 alert
Brenk :
1.0 alert
Leadlikeness :
1.0
Synthetic accessibility :
3.32
Application In Synthesis of [ 16947-84-5 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Downstream synthetic route of [ 16947-84-5 ]
1
[ 186581-53-3 ]
[ 16947-84-5 ]
[ 58457-98-0 ]
Reference:
[1]Journal of Medicinal Chemistry,1998,vol. 41,p. 2786 - 2805
[2]Journal of Medicinal Chemistry,1981,vol. 24,p. 567 - 572
[3]Journal of Medicinal Chemistry,1976,vol. 19,p. 766 - 772
[4]Journal of the American Chemical Society,1992,vol. 114,p. 998 - 1010
2
[ 16947-86-7 ]
[ 501-53-1 ]
[ 16947-84-5 ]
3
[ 6066-82-6 ]
[ 16947-84-5 ]
(S)-2-Benzyloxycarbonylamino-3-tert-butoxycarbonylamino-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester
[ No CAS ]
4
[ 24424-99-5 ]
[ 35761-26-3 ]
[ 16947-84-5 ]
Reference:
[1]European Journal of Organic Chemistry,2014,vol. 2014,p. 7015 - 7022
[2]Organic Letters,2006,vol. 8,p. 5009 - 5012
[3]Tetrahedron,2000,vol. 56,p. 2513 - 2522
[4]Journal of Medicinal Chemistry,1998,vol. 41,p. 2786 - 2805
[5]Synlett,2008,p. 513 - 516
[6]Tetrahedron,1996,vol. 52,p. 2945 - 2956
[7]Tetrahedron Asymmetry,2015,vol. 26,p. 1273 - 1280
[8]Tetrahedron Letters,1993,vol. 34,p. 3201 - 3204
[9]Journal of Medicinal Chemistry,1995,vol. 38,p. 2410 - 2417
[10]Journal of Medicinal Chemistry,1997,vol. 40,p. 2064 - 2084
[11]Journal of the American Chemical Society,1992,vol. 114,p. 998 - 1010
5
[ 7598-10-9 ]
[ 16947-84-5 ]
[ 78089-18-6 ]
6
[ 2577-48-2 ]
[ 16947-84-5 ]
(S)-1-((S)-2-Benzyloxycarbonylamino-3-tert-butoxycarbonylamino-propionyl)-pyrrolidine-2-carboxylic acid methyl ester
[ No CAS ]
7
[ 51186-41-5 ]
[ 16947-84-5 ]
[ 130619-14-6 ]
8
[ 16947-84-5 ]
[ 78089-20-0 ]
[ 78089-21-1 ]
9
[ 16947-84-5 ]
[ 78089-23-3 ]
[ 78089-24-4 ]
10
[ 16947-84-5 ]
[ 63328-49-4 ]
[ 130581-88-3 ]
11
[ 16947-84-5 ]
[ 74536-29-1 ]
Reference:
[1]Tetrahedron Letters,1993,vol. 34,p. 3201 - 3204
[2]Journal of Medicinal Chemistry,1998,vol. 41,p. 2786 - 2805
[3]Journal of Medicinal Chemistry,1995,vol. 38,p. 2410 - 2417
[4]Tetrahedron,2000,vol. 56,p. 2513 - 2522
[5]Organic Letters,2006,vol. 8,p. 5009 - 5012
12
[ 16947-84-5 ]
[ 541-41-3 ]
[ 91289-64-4 ]
13
[ 73371-96-7 ]
[ 35761-26-3 ]
[ 16947-84-5 ]
14
[ 74536-29-1 ]
[ 501-53-1 ]
[ 16947-84-5 ]
15
[ 16947-84-5 ]
[ 101-83-7 ]
[ 16944-40-4 ]
16
[ 3005-70-7 ]
[ 16947-84-5 ]
[ 161644-76-4 ]
17
[ 16947-84-5 ]
(S)-Prolintrimethylsilylethylester Toluolsulfonsaeure-Komplex
[ No CAS ]
(S)-1-((S)-2-Benzyloxycarbonylamino-3-tert-butoxycarbonylamino-propionyl)-pyrrolidine-2-carboxylic acid 2-trimethylsilanyl-ethyl ester
[ No CAS ]
18
[ 16947-84-5 ]
[ 35761-26-3 ]
Yield Reaction Conditions Operation in experiment
21 g
With trifluoroacetic acid; In dichloromethane; at 20℃;
50 g of the compound <strong>[16947-84-5](S)-N-benzyloxycarbonyl-N'-tert-butoxycarbonyl-2,3-diaminopropionic acid</strong> was dissolved in 500 mL of dichloromethane, and 50 mL of trifluoroacetic acid was added thereto, and the mixture was stirred at room temperature overnight. After completion of the reaction, the mixture was concentrated to dryness, evaporated, evaporated, evaporated.
19
[ 16947-84-5 ]
[ 6638-79-5 ]
[ 173259-61-5 ]